EARNEST Partners’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$90.9M Sell
2,569,653
-93,300
-4% -$3.8M 0.37% 105
2025
Q4
$108M Sell
2,662,953
-135,750
-5% -$5.91M 0.46% 85
2025
Q3
$132M Sell
2,798,703
-31,212
-1% -$1.62M 0.57% 61
2025
Q2
$147M Buy
2,829,915
+30,216
+1% +$1.66M 0.66% 51
2025
Q1
$169M Sell
2,799,699
-10,477
-0.4% -$675K 0.81% 33
2024
Q4
$192M Buy
2,810,176
+25,876
+0.9% +$1.8M 0.86% 27
2024
Q3
$200M Sell
2,784,300
-34,306
-1% -$2.42M 0.87% 29
2024
Q2
$195M Buy
2,818,606
+447,498
+19% +$32.6M 0.91% 25
2024
Q1
$190M Buy
2,371,108
+25,411
+1% +$2.26M 0.87% 29
2023
Q4
$257M Buy
2,345,697
+80,605
+4% +$8.33M 1.28% 10
2023
Q3
$228M Buy
2,265,092
+44,076
+2% +$5.06M 1.32% 7
2023
Q2
$302M Sell
2,221,016
-494,873
-18% -$60.4M 1.69% 5
2023
Q1
$282M Buy
2,715,889
+313,537
+13% +$30.3M 1.63% 5
2022
Q4
$213M Buy
2,402,352
+335,974
+16% +$27.9M 1.31% 7
2022
Q3
$166M Buy
2,066,378
+404,586
+24% +$38.2M 1.11% 16
2022
Q2
$159M Buy
1,661,792
+187,134
+13% +$22.5M 1.06% 19
2022
Q1
$219M Sell
1,474,658
-44,665
-3% -$6.24M 1.3% 13
2021
Q4
$215M Sell
1,519,323
-83,807
-5% -$11.9M 1.24% 18
2021
Q3
$210M Sell
1,603,130
-25,718
-2% -$3.36M 1.28% 12
2021
Q2
$224M Sell
1,628,848
-7,824
-0.5% -$1.07M 1.32% 13
2021
Q1
$214M Buy
1,636,672
+61,336
+4% +$7.38M 1.28% 17
2020
Q4
$176M Buy
1,575,336
+459,191
+41% +$43.5M 1.22% 16
2020
Q3
$87.8M Buy
+1,116,145
New +$91M 0.76% 51

Other funds holding CNMD